Comparison of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and C-reactive protein in predicting osteomyelitis in patients with diabetic foot ulcer
Journal of Diabetes & Metabolic Disorders - Trang 1-8 - 2023
Tóm tắt
Neutrophil/lymphocyte ratio (NLR) and platelet/ lymphocyte ratio (PLR) are readily available and inexpensive biomarkers that have received great attention for diagnosing type 2 diabetes(T2DM) complications. The objective of the present cross-sectional study was to compare diagnostic values of these biomarkers with C-reactive protein(CRP) in detecting diabetic foot ulcer (DFU) and osteomyelitis (OS) and discriminating between the degree of DFU according to Wagner’s classification. A total of 217 individuals (42 healthy controls, 40 T2DM patients without DFU, and 135 patients with DFU) were enrolled. The DFU patients were classified according to Wagner’s classification into grade 1, grade 2, and grade 3. Blood samples were obtained and various biochemical and hematological parameters including creatine, CRP, HbA1c, NLR, and PLR were measured. The levels of CRP, PLR, and NLR were significantly higher in the patients with DFU and OS compared to healthy controls and T2DM patients without DFU. The median values of CRP were correlated with the severity of DFU and increased with DFU grades. The highest values of CRP, NLR, and PLR were observed in the DFU patients with OS which were significantly higher than those of DFU patients with grades 1 and 2 as well as T2DM patients without DFU. The PLR and NLR had no significant performance in diagnosing DFU patients with grades 1 and 2 from the patients without DFU. NLR and PLR could be useful for diagnosing OS but cannot be used for detecting lower grades of DFU. CRP showed higher performance in detecting OS compared to PLR and NLR.
Tài liệu tham khảo
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.
Zeng J, Chen M, Feng Q, Wan H, Wang J, Yang F, et al. The platelet-to-lymphocyte ratio predicts Diabetic Retinopathy in type 2 diabetes Mellitus. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy. 2022;15:3617–26.
Syauta D, Hendarto J, Mariana N, Kusumanegara J, Faruk M. Risk factors affecting the degree of diabetic foot ulcers according to Wagner classification in diabetic foot patients. Med Clínica Práctica. 2021;4:100231.
Khunkaew S, Fernandez R, Sim J. Health-related quality of life among adults living with diabetic foot ulcers: a meta-analysis. Qual Life Res. 2019;28(6):1413–27.
Edmonds M, Manu C, Vas P. The current burden of diabetic foot disease. J Clin Orthop Trauma. 2021;17:88–93.
Tang WH, Zhao YN, Cheng ZX, Xu JX, Zhang Y, Liu XM. Risk factors for diabetic foot ulcers: a systematic review and meta-analysis. Vascular. 2023. 17085381231154805.
Pena G, Armstrong DG, Mills JL, Fitridge R. Pathophysiology and principles of management of the Diabetic Foot. Mechanisms of Vascular Disease: Springer; 2020. pp. 563–91.
Bolajoko EB, Mossanda KS, Adeniyi F, Akinosun O, Fasanmade A, Morapane M. Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer. South Afr Med J. 2008;98(8):614–7.
Ghareghani O, Ghareghani S, Takhshid MA. Diagnostic values of ischemia modified albumin in diabetes-related complications: a narrative review. J Diabetes Metabolic Disorders. 2022:1–12.
Alay H, Laloglu E, Kesmez Can F. An evaluation of ischemia-modified albumin levels in the development of diabetic foot ulcer. Int J Clin Pract. 2021;75(9):e14589.
Kim K, Mahajan A, Patel K, Syed S, Acevedo-Jake AM, Kumar VA. Materials and cytokines in the Healing of Diabetic Foot Ulcers. Adv Ther. 2021;4(9):2100075.
Van Asten SA, Nichols A, La Fontaine J, Bhavan K, Peters EJ, Lavery LA. The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis. Int Wound J. 2017;14(1):40–5.
Zakariah NA, Bajuri MY, Hassan R, Ismail Z, Mansor MM, Othman H, et al. Is procalcitonin more superior to hs-CRP in the diagnosis of infection in diabetic foot ulcer? Malays J Pathol. 2020;42(1):77–84.
Wang L, Li Q, Chen X, Wang Z. Clinical characteristics and risk factors of lower extremity amputation in patients with diabetic foot. Pakistan J Med Sci. 2022;38(8):2253–8.
Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biometrical J Biometrische Z. 2005;47(4):458–72.
Giurato L, Meloni M, Izzo V, Uccioli L. Osteomyelitis in diabetic foot: a comprehensive overview. World J Diabetes. 2017;8(4):135–42.
Ramanujam CL, Han D, Zgonis T. Medical imaging and laboratory analysis of diagnostic accuracy in 107 consecutive hospitalized patients with diabetic foot osteomyelitis and partial foot amputations. Foot Ankle Spec. 2018;11(5):433–43.
Wang JR, Chen Z, Yang K, Yang HJ, Tao WY, Li YP, et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. 2020;12:55.
Akbas EM, Demirtas L, Ozcicek A, Timuroglu A, Bakirci EM, Hamur H, et al. Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. Int J Clin Exp Med. 2014;7(7):1794–801.
Demirtas L, Degirmenci H, Akbas EM, Ozcicek A, Timuroglu A, Gurel A, et al. Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med. 2015;8(7):11420–7.
Liu N, Sheng J, Pan T, Wang Y. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are Associated with Lower Extremity Vascular Lesions in chinese patients with type 2 diabetes. Clin Lab. 2019;65(3).
Atak B, Aktas G, Duman TT, Erkus E, Kocak MZ, Savli H. Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Revista da Associacao Medica Brasileira (1992). 2019;65(1):38–42.
Zhang K, Ding S, Lyu X, Tan Q, Wang Z. Correlation between the platelet-to-lymphocyte ratio and diabetic foot ulcer in patients with type 2 diabetes mellitus. J Clin Lab Anal. 2021;35(4):e23719.
Sánchez-Rosales AI, Guadarrama-López AL, Gaona-Valle LS, Martínez-Carrillo BE, Valdés-Ramos R. The effect of dietary patterns on inflammatory biomarkers in adults with type 2 diabetes Mellitus: a systematic review and Meta-analysis of Randomized controlled trials. Nutrients. 2022;14(21).
Kim BJ, Cho SH, Cho KI, Kim HS, Heo JH, Cha TJ. The combined impact of Neutrophil-to-lymphocyte ratio and type 2 Diabetic Mellitus on significant coronary artery disease and carotid artery atherosclerosis. J Cardiovasc Ultrasound. 2016;24(2):115–22.
Li X, Shen J, Lu Z, Chen M, Fang X, Wang G. High neutrophil-to-lymphocyte ratio is associated with increased carotid artery intima-media thickness in type 2 diabetes. J Diabetes Invest. 2017;8(1):101–7.
Xu T, Weng Z, Pei C, Yu S, Chen Y, Guo W, et al. The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in type 2 diabetes mellitus. Medicine. 2017;96(45):e8289.
Adaikalakoteswari A, Rema M, Mohan V, Balasubramanyam M. Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy. Int J Biochem Cell Biol. 2007;39(9):1673–84.
Gary T, Pichler M, Belaj K, Hafner F, Gerger A, Froehlich H, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS ONE. 2013;8(7):e67688.
Mineoka Y, Ishii M, Hashimoto Y, Yamashita A, Nakamura N, Fukui M. Platelet to lymphocyte ratio correlates with diabetic foot risk and foot ulcer in patients with type 2 diabetes. Endocr J. 2019;66(10):905–13.
Demirdal T, Sen P. The significance of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and lymphocyte-monocyte ratio in predicting peripheral arterial disease, peripheral neuropathy, osteomyelitis and amputation in diabetic foot infection. Diabetes Res Clin Pract. 2018;144:118–25.
Yapıcı O, Berk H, Öztoprak N, Seyman D, Tahmaz A, Merdin A. Can ratio of neutrophil-to-lymphocyte count and erythrocyte sedimentation rate in diabetic foot infecti on predict osteomyelitis and/or amputation? Hematol Rep. 2017;9(1):6981.
Ong E, Farran S, Salloum M, Gardner S, Giovinco N, Armstrong DG, et al. Does everything that’s counted Count? Value of inflammatory markers for following Therapy and Predicting Outcome in Diabetic Foot infection. Int J Low Extrem Wounds. 2017;16(2):104–7.
Jeandrot A, Richard J-L, Combescure C, Jourdan N, Finge S, Rodier M, et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia. 2008;51:347–52.
Hadavand F, Amouzegar A, Amid H. Pro-calcitonin, erythrocyte sedimentation rate and C-reactive protein in predicting diabetic foot ulcer characteristics; a cross sectional study. Archives of Academic Emergency Medicine. 2019;7(1).
Guo Z, Yue C, Qian Q, He H, Mo Z. Factors associated with lower-extremity amputation in patients with diabetic foot ulcers in a chinese tertiary care hospital. Int Wound J. 2019;16(6):1304–13.